RUA Life Sciences plc / Fundamentals
Income statement
- Net revenue
€5.51M - Cost of goods sold
€1.65M - Gross profit
€3.86M - SG&A expenses
€6.54M - R&D expenses
€2.27M - EBITDA
-€1.97M - D&A
€835.35K - EBIT
-€4.08M - Interest expenses
€140.38K - EBT
-€2.95M - Tax expenses
-€1.04M - Net income
-€1.91M
Cash flow statement
- Net deferred tax
-€231.27K - Non-cash items
-€965.37K - Changes in working capital
-€154.18K - Operating cash flow
-€2.61M - Capex
€512.02K - Other investing cash flow
-€56.38K - Net investing cash flow
-€283.05K - Total cash dividends paid
€0.00 - Issuance of common stock
€4.57M - Debt repayment
-€162.24K - Other financing cash flow
€4.59M - Net financing cash flow
€4.43M - Foreign exchange effects
-€18.41K - Net change in cash
€1.64M - Cash at end of period
€4.35M - Free cash flow
-€2.10M
Balance sheet
- Cash and cash equivalents
€4.35M - Cash and short-term investments
€4.35M - Total receivables
€1.17M - Inventory
€1.28M - Other current assets
€0.00 - Total current assets
€6.80M - Property, plant & equipment
€3.48M - Goodwill
€346.34K - Intangible assets
€654.70K - Long-term investments
€0.00 - Other non-current assets
€0.00 - Total non-current assets
€4.49M - Total assets
€11.28M - Accounts payable
€132.32K - Short-term debt
€471.75K - Other current liabilities
€446.44K - Total current liabilities
€1.05M - Long-term debt
€881.37K - Deferred tax liabilities
€79.39K - Other non-current liabilities
€82.84K - Total non-current liabilities
€1.04M - Total liabilities
€2.09M - Common stock
€3.57M - Retained earnings
-€22.27M - Other equity
€11.97M - Total equity
€9.19M - Total liabilities and shareholders' equity
€11.28M
Company information
- Market capitalization
€8.99M - Employees
40 - Enterprise Value
€4.74M
Company ratios
- Gross margin
-
70.0% Much better than peer group: 37.0% - EBITDA margin
-
-35.8% Much worse than peer group: 6.6% - EBIT margin
-
-74.1% Much worse than peer group: 2.4% - EBT margin
-
-53.5% Much worse than peer group: -12.0% - Net margin
-
-34.7% Much worse than peer group: -14.3% - ROE
-
-20.8% Much better than peer group: -366.2% - ROA
-
-17.0% Much better than peer group: -300.7% - Asset turnover
-
48.8% Much better than peer group: 18.2% - FCF margin
-
-56.7% Much worse than peer group: -3.7% - FCF yield
-34.8% - Efficiency ratio
135.8% - Net sales per employee
-
€137.79K - Net income per employee
-
-€47.87K